Skip to main content
ACROBIOSYSTEMS CO.,LTD. logo

ACROBIOSYSTEMS CO.,LTD. - Investor Relations & Filings

Listed IPO Oct 2021
Ticker · 301080 ISIN · CNE100004S13 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 635 across all filing types
Latest filing 2026-07-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301080 · 1 venue

About ACROBIOSYSTEMS CO.,LTD.

https://www.acrobiosystems.cn

ACROBIOSYSTEMS CO.,LTD. is a global biotechnology company specializing in the development and manufacturing of high-quality recombinant proteins and critical reagents for the life sciences industry. The company provides a comprehensive portfolio of products designed to accelerate the development of target therapeutics, including antibodies, cell and gene therapies, and vaccines. Key offerings include a wide range of biotinylated proteins, enzymes, and assay kits characterized by high bioactivity and batch-to-batch consistency. ACROBIOSYSTEMS supports drug discovery and clinical development through specialized platforms for protein engineering and characterization. Its products serve a diverse client base of pharmaceutical companies, biotechnology firms, and academic research institutions worldwide, focusing on therapeutic areas such as oncology, immunology, and infectious diseases.

Recent filings

Filing Released Lang Actions
回购报告书
Regulatory Filings
2026-07-21 Chinese
关于选举职工董事的公告
Board/Management Information Classification · 100% confidence The document is an official announcement regarding the election of a new employee representative director (职工董事) for the company's board. This falls under the category of changes in the company's board of directors or senior management.
2026-07-16 Chinese
上海市通力律师事务所北京分所关于北京百普赛斯生物科技股份有限公司2026年第二次临时股东会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a 'Legal Opinion' (法律意见书) issued by a law firm regarding the proceedings and voting results of an Extraordinary General Meeting (EGM). It details the meeting's convocation, attendee qualifications, and the specific voting results for various agenda items (board elections and share repurchase). While it contains voting results, it is a legal attestation document rather than the company's official 'Declaration of Voting Results' (DVA) filing itself. In the context of Chinese corporate filings, such legal opinions are standard attachments to the official DVA announcement. Since the document is a legal opinion confirming the validity of the meeting, it falls under the 'Regulatory Filings' (RNS) category as a miscellaneous regulatory/compliance document.
2026-07-16 Chinese
关于回购股份用于注销并减少注册资本暨通知债权人的公告
Regulatory Filings Classification · 90% confidence The document is an official announcement from Beijing AcroBiosystems regarding a share repurchase program intended for cancellation and the subsequent reduction of registered capital. It serves as a formal notice to creditors to exercise their rights to claim debt or request guarantees within 45 days. This type of corporate action announcement, which involves capital structure changes and creditor notification, falls under the 'Regulatory Filings' (RNS) category as it is a specific regulatory disclosure requirement in the Chinese market that does not fit into the more specific categories like 'Share Issue' (SHA) or 'Transaction in Own Shares' (POS) which typically cover the execution of trades rather than the legal creditor notification process.
2026-07-16 Chinese
2026年第二次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '2026年第二次临时股东会决议公告' (2026 Second Extraordinary General Meeting Resolution Announcement). It details the voting results of an extraordinary general meeting, including attendance figures, specific voting outcomes for board elections and share repurchase proposals, and a legal opinion from a law firm. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-07-16 Chinese
关于回购股份事项股东会股权登记日前十名股东及前十名无限售条件股东持股情况的公告
Regulatory Filings Classification · 90% confidence The document is an announcement regarding the shareholding status of the top ten shareholders prior to a shareholder meeting related to a share repurchase plan. It provides specific shareholder data as required by regulatory guidelines for share buybacks. While it mentions a share repurchase, it is not a report of a transaction in own shares (POS) nor a general regulatory filing (RNS), but rather a specific disclosure required for the governance and procedural transparency of a corporate action (share repurchase). Given the options, this falls under Regulatory Filings (RNS) as it is a mandatory disclosure document regarding shareholder composition for a specific corporate event.
2026-07-13 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.